Decoding the Triterpenoid Gymnemic Acid Biosynthetic Pathway in Gymnema Sylvestre
DOI:
https://doi.org/10.52783/jns.v14.2434Keywords:
Gymnema sylvestre, Gymnemic acid, Triterpenoid, Gurmarin, Biosynthetic pathwayAbstract
Gymnemic acid, a bioactive compound with potential medicinal properties, is synthesized by a complex enzymatic process known as the denovo biosynthetic pathway. This pathway involves a series of well-coordinated steps starting from acetyl Co A till the synthesis of gymnemic acid, each series of reaction is catalyzed by biochemical conversion involving 15 enzymes. The enzymes required to catalyze the conversion of cochalicic acid to acacic acid and acacic acid to gymnemic acid have not been reported previously. Hence, this study highlights the link missing in the complex biomolecular transformation leading to synthesis of gymnemic acid. This is the first report to identify these enzymes as acacic acid synthase and gymnemic acid synthase. Additionally, organized schematic representation of biosynthetic pathway was deduced.
Downloads
Metrics
References
Tripathy, T., Das, S., Singh, D. P., Dwivedi, R., Sahu, D. R., Prusty, U., Pradhan, P. B., Pattanaik, J. K., Pandey, S., Tripathy, A., Tripathy, S., & Singh, R. (2024). Gymnema sylvestre- An Indian Drug in Homoeopathy. Global Academic Journal of Medical Sciences, 6(05), 224–227. https://doi.org/10.36348/gajms.2024.v06i05.002.
Abdelmonem, M., Wasim, H., Ghanem, A., Elebeedy, D., Abdelmaksoud, A., & Badawy, I. (2024). Enhanced Antidiabetic Effects of Gymnema sylvestre and Probiotics in Alloxan-Induced Diabetic Rats. American Journal of Clinical Pathology, 162 (Supplement_1), S37–S38. https://doi.org/10.1093/ajcp/aqae129.082
Kumari, V. (2024). Ethnopharmacological Importance of Gymnema sylvestre. European Journal of Medicinal Plants, 35(6), 224–233. https://doi.org/10.9734/ejmp/2024/v35i61221
Bolem, V. R. S. S., Kavala, R., Mangam, V. T., & Sarella, P. N. K. (2023). Phytochemical Composition and Antidiabetic Potential of Gymnema sylvestre Extracts and Formulations. International Journal of Pharmaceutical Sciences and Medicine, 8(7), 58–66. https://doi.org/10.47760/ijpsm.2023.v08i07.006
Maaroufi, H. (2024). Novel Gurmarin-like Peptides from Gymnema sylvestre and their Interactions with the Sweet Taste Receptor T1R2/T1R3. Chemical Senses. https://doi.org/10.1093/chemse/bjae018
Luo H, Wang LF, Imoto T, Hiji Y. Inhibitory effect and mechanism of acarbose combined with gymnemic acid on maltose absorption in rat intestine. World J Gastroenterol 2001; 7(1): 9-15.
Kanetkar, P., Singhal, R., & Kamat, M. (2007). Gymnema sylvestre: A Memoir. Journal of clinical biochemistry and nutrition, 41(2), 77–81. https://doi.org/10.3164/jcbn.2007010
Vieira, R., Souto, S. B., Sánchez-López, E., López Machado, A., Severino, P., Jose, S., Santini, A., Fortuna, A., García, M. L., Silva, A. M., & Souto, E. B. (2019). Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I. Pharmaceuticals, 12(4), 152. https://doi.org/10.3390/ph12040152.
Muzaffar, H., Qamar, I., Bashir, M., Jabeen, F., Irfan, S., & Anwar, H. (2023). Gymnema sylvestre Supplementation Restores Normoglycemia, Corrects Dyslipidemia, and Transcriptionally Modulates Pancreatic and Hepatic Gene Expression in Alloxan-Induced Hyperglycemic Rats. Metabolites, 13(4), 516. https://doi.org/10.3390/metabo13040516
Wh, H., R, K., C, D., I, N., E, S., & A, A. (2025). The effect of a 14-day Gymnema sylvestre intervention to reduce sugar intake in people self-identifying with a sweet tooth. Appetite, 207, 107871. https://doi.org/10.1016/j.appet.2025.107871
Miranda, D. G., Tomé, F. M., Miguel, M. M. V., Liberato, S. F. d. S., Marcucci, M. C., Vigerelli, H., Rodrigues, F. P., Pacheco-Soares, C., Godoi, B. H., Carrouel, F., de Oliveira, L. D., & Ramos, L. d. P. (2025). Gymnema sylvestre as a Potential Anti-Inflammatory and Anti-Biofilm Agent Against Anaerobic Infections: An In Vitro Study. Plants, 14(4), 497. https://doi.org/10.3390/plants14040497
Ros, S., García-Rocha, M., Calbó, J. et al. (2011). Restoration of hepatic glycogen deposition reduces hyperglycaemia, hyperphagia and gluconeogenic enzymes in a streptozotocin-induced model of diabetes in rats. Diabetologia 54, 2639–2648, https://doi.org/10.1007/s00125-011-2238-x.
Tiwari, P., Mishra, B. N., & Sangwan, N. S. (2014). Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plant. BioMed research international, 2014, 830285. https://doi.org/10.1155/2014/830285.
Nazaruk, J., Borzym-Kluczyk, M. The role of triterpenes in the management of diabetes mellitus and its complications. Phytochem Rev 14, 675–690 (2015). https://doi.org/10.1007/s11101-014-9369-x.
Kalariya, K. A., Minipara, D. B., & Manivel, P. (2018). De novo transcriptome analysis deciphered polyoxypregnane glycoside biosynthesis pathway in Gymnema sylvestre. 3 Biotech, 8(9), 381. https://doi.org/10.1007/s13205-018-1389-6
Kalariya, K. A., Gajbhiye, N., Minipara, D., Meena, R. P., Kumar, S., Saha, A., ... & Manivel, P. (2019). Deep sequencing-based de novo transcriptome analysis reveals biosynthesis of gymnemic acid in Gymnema sylvestre (Retz.) Schult. Ecological Genetics and Genomics, 13, 100047.
Ayachit, G., Shaikh, I., Sharma, P., Jani, B., Shukla, L., Sharma, P., Bhairappanavar, S. B., Joshi, C., & Das, J. (2019). De novo transcriptome of Gymnema sylvestre identified putative lncRNA and genes regulating terpenoid biosynthesis pathway. Scientific Reports, 9(1), 14876. https://doi.org/10.1038/s41598-019-51355-x
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
